GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (BSP:I2TC34) » Definitions » FFO

Intra-Cellular Therapies (BSP:I2TC34) FFO


View and export this data going back to 2023. Start your Free Trial

What is Intra-Cellular Therapies FFO?

FFO (Funds from operations) only applies to REITs.


Intra-Cellular Therapies Business Description

Traded in Other Exchanges
Address
135 Route 202/206, Suite 6, Bedminster, NJ, USA, 07921
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. It maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.